Ftse Mib
33.167,64
0,00%
DAX
19.295,98
-0,59%
S&P 500
6.021,63
0,57%
NASDAQ
19.175,58
0,63%
Bitcoin
92.800,78
0,90%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Europa EU Transgene SA (TNG) Transgene SA (TNG) Notizie

Transgene SA

TNG
0,00
0,00 (0,00%)
- - Chiuso
Dati in Delay di 15 minuti
Borsa: Euronext
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
07/11/202417:45GLOBETransgene Reports Business, Pipeline and Financial Update..
07/11/202417:45UKREGTransgene and NEC Present New Data Confirming Clinical Proof..
07/11/202417:45UKREGTransgene fait le point sur ses activités, son portefeuille..
07/11/202417:45UKREGTransgene et NEC présentent de nouvelles données confirmant..
07/11/202417:45UKREGTransgene Reports Business, Pipeline and Financial Update..
05/11/202407:30GLOBETransgene and ProBioGen Join Forces to Advance..
05/11/202407:30UKREGTransgene and ProBioGen Join Forces to Advance..
05/11/202407:30UKREGTransgene et ProBioGen collaborent pour faire progresser le..
14/10/202407:30GLOBETransgene Provides Update on Phase II Trial of Therapeutic..
14/10/202407:30UKREGTransgene fait le point sur l’étude de Phase II du vaccin..
14/10/202407:30UKREGTransgene Provides Update on Phase II Trial of Therapeutic..
07/10/202408:00UKREGTransgene présentera un poster sur les données actualisées..
07/10/202408:00UKREGTransgene to Present a Poster on Updated Data for TG4050 at..
07/10/202408:00GLOBETransgene to Present a Poster on Updated Data for TG4050 at..
24/9/202417:45GLOBETransgene to Report Major Clinical Data before the end of..
24/9/202417:45UKREGMise à disposition du Rapport Financier Semestriel au 30..
24/9/202417:45UKREGTransgene prévoit d’importants résultats cliniques d’ici fin..
24/9/202417:45UKREGAvailability of Transgene’s Half-Year Financial Report as..
24/9/202417:45UKREGTransgene to Report Major Clinical Data before the end of..
24/9/202417:45UKREG2024 Half-Year Financial Report
24/9/202417:45UKREGRapport Semestriel 2024
14/9/202409:05UKREGLe virus oncolytique BT-001 de Transgene et BioInvent montre..
14/9/202409:05GLOBETransgene and BioInvent’s Oncolytic Virus BT-001 Shows..
14/9/202409:05UKREGTransgene and BioInvent’s Oncolytic Virus BT-001 Shows..
10/9/202407:30GLOBETransgene Appoints Two Seasoned Leaders in Oncology to Drive..
10/9/202407:30UKREGTransgene Appoints Two Seasoned Leaders in Oncology to Drive..
10/9/202407:30UKREGTransgene nomme deux experts en oncologie pour conduire sa..
09/9/202407:00UKREGTransgene and BioInvent to Present Promising Initial Phase..
09/9/202407:00GLOBETransgene and BioInvent to Present Promising Initial Phase..
09/9/202407:00UKREGTransgene et BioInvent présentent des données cliniques..
05/9/202417:45GLOBETransgene to Participate in HTID Conference and Investor..
27/8/202407:30GLOBETransgene — Preclinical Proof-of-Concept Data of Oncolytic..
27/8/202407:30UKREGTransgene publie dans le JITC des données de preuve de..
27/8/202407:30UKREGTransgene — Preclinical Proof-of-Concept Data of Oncolytic..
31/7/202417:00UKREGTransgene annonce la mise à disposition d’un prospectus ..
30/7/202421:01UKREGTransgene renforce son bilan par la conversion en actions..
22/7/202408:00GLOBETransgene and BioInvent to Present Poster on Oncolytic..
22/7/202408:00UKREGTransgene and BioInvent to Present Poster on Oncolytic..
10/7/202418:00UKREGBalance sheet of the liquidity contract with Natixis Oddo..
10/7/202418:00UKREGBilan du Contrat de Liquidité avec la Société Natixis Oddo..
03/6/202407:30GLOBETransgene - First Patient Enrolled in Phase II Part of..
15/5/202417:45GLOBEAssemblée Générale Mixte de Transgene du 15 mai 2024
14/5/202417:45GLOBETransgene fait le point sur ses activités et sa situation..
24/4/202417:45GLOBEAvailability of Preparatory Documents for the Combined..
11/4/202419:05GLOBEDocument d'enregistrement Universel 2023
11/4/202417:45GLOBEAvailability of Transgene's 2023 Universal Registration..
09/4/202417:45GLOBETransgene et NEC présentent les premiers signes de bénéfice..
27/3/202417:45GLOBETransgene anticipates significant progress from..
18/3/202417:45GLOBETransgene Announces Upcoming Investor Meetings
06/3/202407:30GLOBETransgene présentera de nouvelles données sur son vaccin..
Apertura: Min: Max:
Chiusura:

La tua Cronologia

EU
TNG
Transgene
LSE
MAE
Mallett
NASDAQ
VBFCW
BIT
3SNV
Graniteshares 3x Short N...
ASX
NBL
Noni B
FX
ZARSEK
ZAR vs SEK
NASDAQ
JHFT
NASDAQ
VPF
AMEX
HWG
Hallwood
LSE
MORE
Hostmore
BIT
PST
Poste Italiane S.p.a
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network